These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33248466)

  • 1. WHO launches strategy to accelerate elimination of cervical cancer.
    Das M
    Lancet Oncol; 2021 Jan; 22(1):20-21. PubMed ID: 33248466
    [No Abstract]   [Full Text] [Related]  

  • 2. Global elimination of cervical cancer is achievable-with commitment.
    The Lancet Oncology
    Lancet Oncol; 2019 Nov; 20(11):1467. PubMed ID: 31674306
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for cervical cancer and human papillomavirus vaccination in Israel: recommendations.
    Bornstein J; Fisher WA; Ginsberg GM; Shavit O; Schejter E; Diaz M; Bosch FX
    Vaccine; 2013 Nov; 31 Suppl 8():I58-60. PubMed ID: 24229721
    [No Abstract]   [Full Text] [Related]  

  • 4. Gardasil: from bench, to bedside, to blunder.
    Bach PB
    Lancet; 2010 Mar; 375(9719):963-4. PubMed ID: 20304226
    [No Abstract]   [Full Text] [Related]  

  • 5. IPVS statement moving towards elimination of cervical cancer as a public health problem.
    Garland SM; Giuliano A; Brotherton J; Moscicki AB; Stanley M; Kaufmann AM; Bhatla N; Sankaranarayanan R; Palefsky JM; de Sanjose S;
    Papillomavirus Res; 2018 Jun; 5():87-88. PubMed ID: 29499389
    [No Abstract]   [Full Text] [Related]  

  • 6. Towards cervical cancer eradication: joint force of HPV vaccination and HPV-based cervical cancer screening.
    Poljak M
    Clin Microbiol Infect; 2015 Sep; 21(9):806-7. PubMed ID: 26068650
    [No Abstract]   [Full Text] [Related]  

  • 7. Global access to HPV vaccination: what are we waiting for?
    Clifford GM
    Lancet; 2009 Dec; 374(9706):1948-9. PubMed ID: 19962186
    [No Abstract]   [Full Text] [Related]  

  • 8. Eliminating cervical cancer: Promising developments in primary prevention.
    Ficht AL; Lapidos-Salaiz I; Phelps BR
    Cancer; 2020 Jan; 126(2):242-246. PubMed ID: 31557324
    [No Abstract]   [Full Text] [Related]  

  • 9. IPVS statement on "Temporary HPV vaccine shortage: Implications globally to achieve equity".
    Garland SM; Stanley MA; Giuliano AR; Moscicki AB; Kaufmann A; Bhatla N; Woo YL;
    Papillomavirus Res; 2020 Jun; 9():100195. PubMed ID: 32205196
    [No Abstract]   [Full Text] [Related]  

  • 10. [Elimination of cervical cancer in Latin America].
    Herrero R
    Salud Publica Mex; 2018; 60(6):621-623. PubMed ID: 30699266
    [No Abstract]   [Full Text] [Related]  

  • 11. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV vaccination strategies targeting hard-to-reach populations: Out-of-school girls in LMICs.
    Bonner K; Banura C; Basta NE
    Vaccine; 2018 Jan; 36(2):191-193. PubMed ID: 29198915
    [No Abstract]   [Full Text] [Related]  

  • 13. National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program.
    Brotherton JM; Leask J; Jackson C; McCaffery K; Trevena LJ
    Sex Health; 2010 Sep; 7(3):291-8. PubMed ID: 20719217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV vaccines: what remains to be done? Interview by Lauren Constable.
    Zur Hausen H
    Expert Rev Vaccines; 2011 Nov; 10(11):1505-7. PubMed ID: 22043949
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.
    Novaes HM; de Soárez PC; Silva GA; Ayres A; Itria A; Rama CH; Sartori AM; Clark AD; Resch S
    Vaccine; 2015 May; 33 Suppl 1():A135-42. PubMed ID: 25919154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV vaccination uptake lowest in young women at greatest risk.
    Ma R
    Practitioner; 2014 Apr; 258(1770):5. PubMed ID: 24881166
    [No Abstract]   [Full Text] [Related]  

  • 17. [Expert consensus on immunoprophylaxis of human papillomavirus-related diseases (abridged)].
    Vaccine and Immunization Branch, Chinese Preventive Medicine Association
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Dec; 53(12):1218-1235. PubMed ID: 31795578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV vaccination: effects on cervical screening.
    Kothari A
    Nurs Times; 2014 Jun 11-17; 110(24):19-21. PubMed ID: 25007499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer prevention in South Africa: HPV vaccination and screening both essential to achieve and maintain a reduction in incidence.
    Botha MH; Richter KL
    S Afr Med J; 2015 Jan; 105(1):33-4. PubMed ID: 26046160
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recommendations for the definition of a policy on vaccination against papillomavirus in Mexico. Strategic Advisory Group of Experts of the World Health Organization].
    Lazcano-Ponce E; Salmerón-Castro J; García-Carrancá A; Aranda-Flores C; Madrid-Marina V; Gómez-Altamirano CM; Martínez-Montañez OG
    Salud Publica Mex; 2009; 51(4):336-41. PubMed ID: 19668929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.